Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castaigne, S.
Right arrow Articles by Degos, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castaigne, S.
Right arrow Articles by Degos, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Does treatment with ARA-C in low dosage cause differentiation of leukemic cells?

S Castaigne, MT Daniel, H Tilly, P Herait and L Degos

A series of 21 patients (5 refractory anemias with an excess of blasts in transformation and 16 acute leukemias) were treated with small doses of ARA-C (10 mg/sq m/12 hr for 15-21 days). Improvement was noted in 15 cases (71%) and complete remission observed in 12 (57%). Complete remission was obtained after one course of treatment in 8 cases. The fact that these patients entered remission relatively slowly and did not suffer marrow aplasia suggests that low-dose ARA-C may function in vivo as it does in vitro, i.e., by inducing differentiation of leukemic blasts.

Volume 62, Issue 1, pp. 85-86, 07/01/1983
Copyright © 1983 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
L. R. Silverman, E. P. Demakos, B. L. Peterson, A. B. Kornblith, J. C. Holland, R. Odchimar-Reissig, R. M. Stone, D. Nelson, B. L. Powell, C. M. DeCastro, et al.
Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B
J. Clin. Oncol., May 15, 2002; 20(10): 2429 - 2440.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. L. Heaney and D. W. Golde
Myelodysplasia
N. Engl. J. Med., May 27, 1999; 340(21): 1649 - 1660.
[Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
F. R. APPELBAUM, R. STORB, R. E. RAMBERG, H. M. SHULMAN, C. D. BUCKNER, R. A. CLIFT, H. J. DEEG, A. FEFER, J. SANDERS, P. STEWART, et al.
Allogeneic Marrow Transplantation in the Treatment of Preleukemia
Ann Intern Med, May 1, 1984; 100(5): 689 - 693.
[Abstract] [PDF]


click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1983 by American Society of Hematology         Online ISSN: 1528-0020